Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shoenfeld, Y.
Right arrow Articles by Pinkhas, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shoenfeld, Y.
Right arrow Articles by Pinkhas, J.
NEUROLOGY 1983;33:243
© 1983 American Academy of Neurology

Fatal peripheral neurolymphomatosis after remission of histiocytic lymphoma

Y. Shoenfeld, MD, D. Aderka, MD, U. Sandbank, MD, N. Gadot, MD, M. Santo, MD and J. Pinkhas, MD.

Departments of Internal Medicine "D," (Drs. Shoenfeld, Aderka, Santo, and Pinkhas) Pathology (Dr. Sandbank) and Neurology, (Dr. Gadot) the Sackler School of Medicine, Tel Aviv University, Beilinson Medical Center, Petah Tikva, Israel.

A 32-year-old woman with histiocytic lymphoma was in complete clinical remission after two courses of chemotherapy, when peripheral neuropathy developed fulminantly. Abnormalities included facial nerve paralysis, dysphagia, quadriparesis, myalgia, and incontinence. She died 10 days after onset of these symptoms. Postmortem examination revealed infiltration of peripheral nerves by lymphomatous cells with no involvement of meninges, brain, lymph nodes, or other organs. Differences in the blood-brain barrier of peripheral and central nervous system are suggested: The peripheral barrier may be more penetrable by malignant histiocytes or less permeable to cytotoxic drugs. Intrathecal chemotherapeutic drug instillation and irradiation may be beneficial.

Address reprint requests to Dr. Shoenfeld, Department of Internal Medicine "D," Beilinson Medical Center, Petah Tikva 49100, Israel.

Address correspondence to Dr. Shoenfeld, Cancer Research Center, 136 Harrison Ave., Boston, MA 02111.

Accepted for publication June 24, 1982.




This article has been cited by other articles:


Home page
J Ultrasound MedHome page
A. L. Choi, S. H. Koh, S. Y. Jun, H. S. Hwang, H. W. Cho, K. M. Jang, E. Y. Jeon, H. Lee, and I. J. Lee
Lymphoma Involving the Ulnar Nerve: Sonographic Findings
J. Ultrasound Med., October 1, 2008; 27(10): 1527 - 1531.
[Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
J. M. Baehring, D. Damek, E. C. Martin, R. A. Betensky, and F. H. Hochberg
Neurolymphomatosis
Neuro-oncol, April 1, 2003; 5(2): 104 - 115.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. A. Krendel, R. L. Stahl, and W. C. Chan
Lymphomatous Polyneuropathy: Biopsy of Clinically Involved Nerve and Successful Treatment
Arch Neurol, March 1, 1991; 48(3): 330 - 332.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by AAN Enterprises, Inc.